DCN and neoplasm: Several studies confirm that reduced expression of decorin in tumor stroma is associated with poor prognosis in metastatic invasive breast cancer and complete absence promotes the progression of several tumor types, including urothelial carcinoma, squamous cell carcinoma, and myeloma [56].